Organogenesis develops regenerative medicine products for advanced wound care, surgical recovery, and sports medicine. It serves hospitals, wound clinics, surgeons, and other healthcare providers with biologic and tissue-based therapies.
Organogenesis products and services overview:
Revenue: ~$458 million
Employees: 900
Headquarters: Canton, United States (USA)
Organogenesis is one of the...
Organogenesis is a company listed under the stock ticker ORGO (US).
View the org chart displaying its 30 main executives
Create your alert
to follow the executive moves at Organogenesis.
Organogenesis has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.